These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5459269)

  • 1. A report from the Australian drug evaluation committee: oral contraceptives and thromboembolic disease.
    Med J Aust; 1970 Jun; 1(25):1267-9. PubMed ID: 5459269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and cancer.
    FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives in 1984.
    Chapler EK
    Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adverse effects of oral contraceptives].
    Gram LF
    Ugeskr Laeger; 1974 Oct; 136(42):2361-6. PubMed ID: 4420288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and venous thromboembolism.
    Paul C
    N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on combination oral contraceptives.
    Smith MA; Youngkin EQ
    Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?
    Speroff L
    Johns Hopkins Med J; 1982 May; 150(5):170-6. PubMed ID: 7043035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for a lower dose pill. Assessing the impact of estrogen dose.
    Brown S; Cropfield O
    ORGYN; 1995; (2):36-9. PubMed ID: 12319251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen content of oral contraceptives and thromboembolitic processes].
    Rübsaam CJ
    Ned Tijdschr Geneeskd; 1970 Jun; 114(26):1101-3. PubMed ID: 5448293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormonal contraceptive therapy and thromboembolic disease].
    Narvaiza MJ; Hernández M; Arrizabalaga B; Solana JM; Pérez Val JA; Rocha E
    Rev Med Univ Navarra; 1980 Dec; 24(4):49-53. PubMed ID: 7038816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens and thromboembolic diseases. Present conception of a controversial issue.
    Zador G
    Acta Obstet Gynecol Scand Suppl; 1976; 54():13-28. PubMed ID: 788441
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.